TrialLancet (London, England)2026

Safety and efficacy of the monoclonal antibody L9LS for malaria prevention in children exposed to perennial malaria transmission in Kenya: a randomised, double-blind, placebo-controlled, phase 2 trial.

Laura C Steinhardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.